Risk factors for retrovirus and hepatitis virus infections in accepted blood donors

Transfusion

Volumn 55, Issue 5, 2015, Pages 1098-1107

  Custer, Brian ^a,b   Kessler, Debra ^c   Vahidnia, Farnaz ^a   Leparc, German ^d   Krysztof, David E ^e   Shaz, Beth ^c   Kamel, Hany ^f   Glynn, Simone ^g   Dodd, Roger Y ^h   Stramer, Susan L ^h  

^a BLOOD SYSTEMS RESEARCH INSTITUTE   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c NEW YORK BLOOD CENTER   (United States)

^d OneBlood   (United States)

^e AMERICAN RED CROSS   (United States)

^f Blood Systems Incorporated   (United States)

^g NATIONAL INSTITUTES OF HEALTH   (United States)

^h HOLLAND LABORATORY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; BLACK PERSON; BLOOD DONOR; CASE CONTROL STUDY; CONTROLLED STUDY; DRUG USE; ETHNICITY; FEMALE; HEPATITIS B; HEPATITIS C; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN T CELL LEUKEMIA VIRUS INFECTION; INFECTION RISK; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; ADOLESCENT; ADVERSE EFFECTS; BLOOD TRANSFUSION; HEPATITIS VIRUS; PATHOGENICITY; RED CROSS; RETROVIRIDAE; RISK FACTOR; STATISTICS AND NUMERICAL DATA; TRANSMISSION; YOUNG ADULT;

ADOLESCENT; ADULT; BLOOD DONORS; BLOOD TRANSFUSION; FEMALE; HEPATITIS B; HEPATITIS C; HEPATITIS VIRUSES; HIV INFECTIONS; HUMANS; MALE; MIDDLE AGED; RED CROSS; RETROVIRIDAE; RISK FACTORS; YOUNG ADULT;

EID: 84929290844     PISSN: 00411132     EISSN: 15372995     Source Type: Journal    
DOI: 10.1111/trf.12951     Document Type: Article

References (37)

1. Whitaker BI, Hinkins S,. The 2011 national blood collection and utilization survey report. Washington, DC: US Department of Health and Human Services; 2013 [cited 2014 Feb 22]. Available from: http://www.hhs.gov/ash/bloodsafety/2011-nbcus.pdf
2. Glynn SA, Kleinman SH, Schreiber GB, et al. Trends in incidence and prevalence of major transfusion-transmissible viral infections in US blood donors, 1991 to 1996. Retrovirus Epidemiology Donor Study (REDS). JAMA 2000;284:229-235.
3. Zou S, Dorsey KA, Notari EP, et al. Prevalence, incidence, and residual risk of human immunodeficiency virus and hepatitis C virus infections among United States blood donors since the introduction of nucleic acid testing. Transfusion 2010;50:1495-1504.
4. Stramer SL, Notari EP, Krysztof DE, et al. Hepatitis B virus testing by minipool nucleic acid testing: does it improve blood safety? Transfusion 2013;53:2449-2458.
5. Zou S, Stramer SL, Dodd RY,. Donor testing and risk: current prevalence, incidence, and residual risk of transfusion-transmissible agents in US allogeneic donations. Transfus Med Rev 2012;26:119-128.
6. Stramer SL, Zou S, Notari EP, et al. Blood donation screening for hepatitis B virus markers in the era of nucleic acid testing: are all tests of value? Transfusion 2012;52:440-446.
7. Van der Bij AK, Coutinho RA, Van der Poel CL,. Surveillance of risk profiles among new and repeat blood donors with transfusion-transmissible infections from 1995 through 2003 in the Netherlands. Transfusion 2006;46:1729-1736.
8. Busch MP,. Lessons and opportunities from epidemiologic and molecular investigations of infected blood donors. Transfusion 2006;46:1663-1666.
9. Orton SL, Stramer SL, Dodd RY, et al. Risk factors for HCV infection among blood donors confirmed to be positive for the presence of HCV RNA and not reactive for the presence of anti-HCV. Transfusion 2004;44:275-281.
10. Belanger GA, McFarland W, Raymond HF, et al. If the permanent deferral were lifted would men who have sex with men want to donate blood, and if so, who would be eligible? Transfusion 2013;53:2729-2733.
11. Cohen IG, Felgenbaum J, Adashl EY,. Reconsideration of the lifetime ban on blood donation by men who have sex with men. JAMA 2014;312:337-338.
12. Sanchez AM, Schreiber GB, Nass CC, et al. The impact of male-to-male sexual experience on risk profiles of blood donors. Transfusion 2005;45:404-413.
13. Division of Blood Applications, Office of Blood Research and Review. Guidance for industry, implementation of acceptable full-length donor history questionnaire and accompanying materials for use in screening donors of blood and blood components. CBER, Food and Drug Administration, US Department of Health and Human Services. 2006 [cited 2014 Oct 1]. Available from: http://www.fda.gov/BiologicsBloodVaccines/GuidanceComplianceRegulatoryInformation/Guidances/Blood/ucm073445.htm
14. American Association of Blood Banks. Blood donor history questionnaires. Washington, D.C., 2014 [cited 2014 Oct 1]. Available from: http://www.aabb.org/tm/questionnaires/Pages/dhqaabb.aspx
15. Stramer SL, Krysztof DE, Brodsky JP, et al. Sensitivity comparison of two Food and Drug Administration-licensed, triplex nucleic acid test automated assays for hepatitis B virus DNA detection and associated projections of United States yield. Transfusion 2011;51:2012-2022.
16. Stramer SL, Notari EP, Zou S, et al. Human T-lymphotropic virus antibody screening of blood donors: rates of false-positive results and evaluation of a potential donor reentry algorithm. Transfusion 2011;51:692-701.
17. McAuley JD, Caglioti S, Williams RC, et al. Clinical significance of nondiscriminated reactive results with the Chiron Procleix HIV-1 and HCV assay. Transfusion 2004;44:91-96.
18. Ownby HE, Korelitz JJ, Busch MP, et al. Loss of volunteer blood donors because of unconfirmed enzyme immunoassay screening results. Retrovirus Epidemiology Donor Study. Transfusion 1997;37:199-205.
19. Sharma UK, Stramer SL, Wright DJ, et al. Impact of changes in viral marker screening assays. Transfusion 2003;43:202-214.
20. Custer B, Kamel H, Kiely NE, et al. Associations between West Nile virus infection and symptoms reported by blood donors identified through nucleic acid test screening. Transfusion 2009;49:278-288.
21. Dodd RY, Stramer SL,. Indeterminate results in blood donor testing: what you don't know can hurt you. Transfus Med Rev 2000;14:151-160.
22. Cleary PD, Singer E, Rogers TF, et al. Sociodemographic and behavioral characteristics of HIV antibody-positive blood donors. Am J Public Health 1988;78:953-957.
23. Murphy EL, Bryzman SM, Glynn SA, et al. Risk factors for hepatitis C virus infection in United States blood donors. NHLBI Retrovirus Epidemiology Donor Study (REDS). Hepatology 2000;31:756-762.
24. Carneiro-Proietti AB, Catalan-Soares BC, Castro-Costa CM, et al. HTLV in the Americas: challenges and perspectives. Rev Panam Salud Publica 2006;19:44-53.
25. Custer B, Sullivan SD, Hazlet TK, et al. Global epidemiology of hepatitis B virus. J Clin Gastroenterol 2004;38:S158-168.
26. de Almeida-Neto C, Goncalez TT, Birch RJ, et al.; NHLBI Retrovirus Epidemiology Donor Study-II International Component B. Risk factors for human immunodeficiency virus infection among Brazilian blood donors: a multicentre case-control study using audio computer-assisted structured interviews. Vox Sang 2013;105:91-99.
27. Zou S, Musavi F, Notari EP, et al. Prevalence, incidence, and residual risk of major blood-borne infections among apheresis collections to the American Red Cross Blood Services, 2004 through 2008. Transfusion 2010;50:1487-1494.
28. Doll LS, Petersen LR, White CR, et al. Human immunodeficiency virus type 1-infected blood donors: behavioral characteristics and reasons for donation. The HIV Blood Donor Study Group. Transfusion 1991;31:704-709.
29. Petersen LR, Doll LS,. Human immunodeficiency virus type 1-infected blood donors: epidemiologic, laboratory, and donation characteristics. The HIV Blood Donor Study Group. Transfusion 1991;31:698-703.
30. US Centers for Disease Control and Prevention. HIV Surveillance Report 2011. 2013 [cited 2014 Jul 1]. Available from: http://www.cdc.gov/hiv/topics/surveillance/resources/reports/
31. McQuillan GM, Coleman PJ, Kruszon-Moran D, et al. Prevalence of hepatitis B virus infection in the United States: the National Health and Nutrition Examination Surveys, 1976 through 1994. Am J Public Health 1999;89:14-18.
32. Shepard CW, Simard EP, Finelli L, et al. Hepatitis B virus infection: epidemiology and vaccination. Epidemiol Rev 2006;28:112-125.
33. Ditah I, Ditah F, Devaki P, et al. The changing epidemiology of hepatitis C virus infection in the United States: National Health and Nutrition Examination Survey 2001 through 2010. J Hepatol 2014;60:691-698.
34. Schreiber GB, Murphy EL, Horton JA, et al. Risk factors for human T-cell lymphotropic virus types I and II (HTLV-I and -II) in blood donors: the Retrovirus Epidemiology Donor Study. NHLBI Retrovirus Epidemiology Donor Study. J Acquir Immune Defic Syndr Hum Retrovirol 1997;14:263-271.
35. Wilson S, Miller K, Ryan M,. Cognitive interviewing study findings of the uniform blood donor history questionnaire. National Center for Health Statistics; 2013.
36. Katz LM, Cumming PD, Wallace EL,. Computer-based blood donor screening: a status report. Transfus Med Rev 2007;21:13-25.
37. Katz LM, Cumming PD, Wallace EL, et al. Audiovisual touch-screen computer-assisted self-interviewing for donor health histories: results from two years experience with the system. Transfusion 2005;45:171-180.